CRISPR: Clashes Over the Future of Gene Therapy at the U.S’s Biggest Biotech Meeting

After 30 years in the making, gene therapy is finally an FDA-approved reality. What comes next?and how will Crispr get a slice of the action?

About Robert Zinn

Robert Zinn, M.D., Ph.D. is a medical doctor, physician, and web entrepreneur, who, for over 15 years was employed by academic and research institutions and focused his clinical practices on very specialized patient populations, such as those with rare genetic diseases or rare cancers. He shares his knowledge through his website,

View all posts by Robert Zinn →